Adsit, S., Zaldivar, E., Sofen, H., Dei-Cas, I., Maldonado-Garcia, C., Penaranda, E., . . . Guana, A. (2017). Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials.
Citación estilo ChicagoAdsit, S., et al. Secukinumab Is Efficacious and Safe in Hispanic Patients With Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials. 2017.
Cita MLAAdsit, S., et al. Secukinumab Is Efficacious and Safe in Hispanic Patients With Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials. 2017.
Precaución: Estas citas no son 100% exactas.